PMC:7126544 / 62339-62467 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T31449","span":{"begin":12,"end":23},"obj":"Chemical"},{"id":"T45116","span":{"begin":84,"end":95},"obj":"Chemical"},{"id":"T99826","span":{"begin":106,"end":121},"obj":"Chemical"},{"id":"T75251","span":{"begin":117,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A34622","pred":"chebi_id","subj":"T31449","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A12337","pred":"chebi_id","subj":"T45116","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A35131","pred":"chebi_id","subj":"T99826","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A22301","pred":"chebi_id","subj":"T75251","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"ho received oseltamivir. And in Guan's study, 35.8% (393/1099) of patients received oseltamivir [85]. The anti-viral drug remdes"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T495","span":{"begin":25,"end":101},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ho received oseltamivir. And in Guan's study, 35.8% (393/1099) of patients received oseltamivir [85]. The anti-viral drug remdes"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1598","span":{"begin":66,"end":74},"obj":"Species"},{"id":"1608","span":{"begin":12,"end":23},"obj":"Chemical"},{"id":"1609","span":{"begin":84,"end":95},"obj":"Chemical"}],"attributes":[{"id":"A1598","pred":"tao:has_database_id","subj":"1598","obj":"Tax:9606"},{"id":"A1608","pred":"tao:has_database_id","subj":"1608","obj":"MESH:D053139"},{"id":"A1609","pred":"tao:has_database_id","subj":"1609","obj":"MESH:D053139"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ho received oseltamivir. And in Guan's study, 35.8% (393/1099) of patients received oseltamivir [85]. The anti-viral drug remdes"}